Literature DB >> 31900515

[Paraneoplastic subacute degeneration of the cerebellum in non-small cell lung cancer and positive anti-Tr3 antibodies].

M Frackowiak1, M Kowar2, Ch Sippel1, K Wilhelm1, Y-D Ko1, A H Jacobs1.   

Abstract

Neurological disorders can occur before the diagnosis of a malignoma is set. These disorders are induced by a misguided immune response with antibodies against intracellular or cell surface antigens. One of the most common paraneoplastic diseases is the subacute degeneration of the cerebellum. In most of the cases antibodies against Anti Hu, CRMP5/CV2, Amphiphysin and Ma/Ta are found and small cell bronchial carcinoma, breast cancer and lymphoma are diagnosed. We report about a 67 years old man with cerebellar symptoms and a weight loss of 10 kg who was treated in our clinic. After our diagnostic work up we found a non small cell cancer and diagnosed a subacute degeneration of the cerebellum as a paraneoplastic disorder. We found a high positive titer for Anti-Tr3 antibodies while the rest of the paraneoplastic antibodies described as typically associated with the subacute degeneration of the cerebellum were negative. The Anti-Tr3 antibodies are usually found in patients with Hodgkin and less often Non-Hodgkin disease. After initiation of a tumor specific therapy and intravenous immunoglobulin therapy the cerebellar symptoms decreased. In future follow up examinations we will see if the anti-Tr3 antibodies were associated with the non small cell bronchial carcinoma or if a lymphoma will occur in our patient.

Entities:  

Keywords:  Ataxie; Cancer; Diagnostic; Dysarthria; Therapy

Mesh:

Substances:

Year:  2020        PMID: 31900515     DOI: 10.1007/s00115-019-00859-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

1.  Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.

Authors:  F Bernal; S Shams'ili; I Rojas; R Sanchez-Valle; A Saiz; J Dalmau; J Honnorat; P Sillevis Smitt; F Graus
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

2.  Clinical insights into paraneoplastic cerebellar degeneration.

Authors:  R Scheid; R Voltz; S Briest; R Kluge; D Y von Cramon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

3.  [Reversible paraneoplastic cerebellar symptoms. An example of anti-Ri syndrome].

Authors:  G Pfeiffer; C Grupp
Journal:  Nervenarzt       Date:  1998-06       Impact factor: 1.214

4.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

5.  [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].

Authors:  A Bartos; P Stourac; R Rusina; M Sejdová; Z Velenská
Journal:  Nervenarzt       Date:  2002-10       Impact factor: 1.214

6.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

7.  Cerebellar degeneration with Hodgkin disease. An immunological study.

Authors:  J L Trotter; B A Hendin; C K Osterland
Journal:  Arch Neurol       Date:  1976-09

8.  Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.

Authors:  Tatjana Seute; Pieter Leffers; Guul P M ten Velde; Albert Twijnstra
Journal:  Cancer       Date:  2004-02-15       Impact factor: 6.860

9.  Paraneoplastic cerebellar degeneration as initial presentation of renal cell carcinoma.

Authors:  Sara M Souza; Barbara O Santos; Isadora C A Sodré; Ana Luiza P Oliveira; Diogo Terrana; Mariana Spitz
Journal:  Cerebellum Ataxias       Date:  2019-07-10

10.  Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.

Authors:  Montserrat Miret; Erzsébet Horváth-Puhó; Anouk Déruaz-Luyet; Henrik Toft Sørensen; Vera Ehrenstein
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.